The Female Reproductive Tract Microbiota: Friends and Foe

Overview

Journal Life (Basel)

Specialty Biology

Date 2023 Jun 28

PMID 37374096

Authors

Lokesh Kumar

Monika Dwivedi

Natasha Jain

Pranali Shete

Subhash Solanki

Rahul Gupta

Ashish Jain

Affiliations

Soon will be listed here.

Abstract

We do not seem to be the only owner of our body; it houses a large population of microorganisms. Through countless years of coevolution, microbes and hosts have developed complex relationships. In the past few years, the impact of microbial communities on their host has received significant attention. Advanced molecular sequencing techniques have revealed a remarkable diversity of the organ-specific microbiota populations, including in the reproductive tract. Currently, the goal of researchers has shifted to generate and perceive the molecular data of those hidden travelers of our body and harness them for the betterment of human health. Recently, microbial communities of the lower and upper reproductive tract and their correlation with the implication in reproductive health and disease have been extensively studied. Many intrinsic and extrinsic factors influences the female reproductive tract microbiota (FRTM) that directly affects the reproductive health. It is now believed that FRTM dominated by may play an essential role in obstetric health beyond the woman's intimate comfort and well-being. Women with altered microbiota may face numerous health-related issues. Altered microbiota can be manipulated and restored to their original shape to re-establish normal reproductive health. The aim of the present review is to summarize the FRTM functional aspects that influence reproductive health.

Citing Articles

Vulvar Lichen Sclerosus: A Literature Review with Consideration of Integrative Therapies.

Jade K Integr Med (Encinitas). 2025; 24(1):16-25.

PMID: 39896832 PMC: 11778321.

Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections.

Avitabile E, Menotti L, Croatti V, Giordani B, Parolin C, Vitali B Int J Mol Sci. 2024; 25(17).

PMID: 39273118 PMC: 11395631. DOI: 10.3390/ijms25179168.

Understanding the Role of Female Genital Tract Microbiome in Recurrent Implantation Failure.

Lafioniatis A, Samara A, Makaritsis P, Dafopoulos S, Sotiriou S, Dafopoulos K J Clin Med. 2024; 13(11).

PMID: 38892884 PMC: 11172434. DOI: 10.3390/jcm13113173.

Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.

Zeber-Lubecka N, Kulecka M, Dabrowska M, Baginska-Drabiuk K, Glowienka-Stodolak M, Nowakowski A PLoS One. 2024; 19(4):e0302270.

PMID: 38669258 PMC: 11051640. DOI: 10.1371/journal.pone.0302270.

Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer.

Shen J, Sun H, Chu J, Gong X, Liu X Infect Agent Cancer. 2024; 19(1):13.

PMID: 38641803 PMC: 11027553. DOI: 10.1186/s13027-024-00573-8.

References

Tomaiuolo R, Veneruso I, Cariati F, DArgenio V . Microbiota and Human Reproduction: The Case of Female Infertility. High Throughput. 2020; 9(2). PMC: 7349014. DOI: 10.3390/ht9020012. View

Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss J . The NIH Human Microbiome Project. Genome Res. 2009; 19(12):2317-23. PMC: 2792171. DOI: 10.1101/gr.096651.109. View

Makarova K, Slesarev A, Wolf Y, Sorokin A, Mirkin B, Koonin E . Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A. 2006; 103(42):15611-6. PMC: 1622870. DOI: 10.1073/pnas.0607117103. View

Kacerovsky M, Vrbacky F, Kutova R, Pliskova L, Andrys C, Musilova I . Cervical microbiota in women with preterm prelabor rupture of membranes. PLoS One. 2015; 10(5):e0126884. PMC: 4439143. DOI: 10.1371/journal.pone.0126884. View

Petricevic L, Rosicky I, Kiss H, Janjic N, Kaufmann U, Holzer I . Effect of vaginal probiotics containing Lactobacillus casei rhamnosus (Lcr regenerans) on vaginal dysbiotic microbiota and pregnancy outcome, prospective, randomized study. Sci Rep. 2023; 13(1):7129. PMC: 10154324. DOI: 10.1038/s41598-023-34275-9. View

Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M . Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect. 2008; 15(1):67-74. DOI: 10.1111/j.1469-0691.2008.02112.x. View

Beghini J, Linhares I, Giraldo P, Ledger W, Witkin S . Differential expression of lactic acid isomers, extracellular matrix metalloproteinase inducer, and matrix metalloproteinase-8 in vaginal fluid from women with vaginal disorders. BJOG. 2014; 122(12):1580-5. DOI: 10.1111/1471-0528.13072. View

Dareng E, Ma B, Famooto A, Adebamowo S, Offiong R, Olaniyan O . Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. Epidemiol Infect. 2015; 144(1):123-37. PMC: 4659743. DOI: 10.1017/S0950268815000965. View

Brotman R, Shardell M, Gajer P, Fadrosh D, Chang K, Silver M . Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2018; 25(11):1321-1330. DOI: 10.1097/GME.0000000000001236. View

10.

Lewis W, Robinson L, Gilbert N, Perry J, Lewis A . Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis. J Biol Chem. 2013; 288(17):12067-79. PMC: 3636892. DOI: 10.1074/jbc.M113.453654. View

11.

Boskey E, Cone R, Whaley K, Moench T . Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod. 2001; 16(9):1809-13. DOI: 10.1093/humrep/16.9.1809. View

12.

Bohbot J, Darai E, Bretelle F, Brami G, Daniel C, Cardot J . Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J Gynecol Obstet Hum Reprod. 2017; 47(2):81-86. DOI: 10.1016/j.jogoh.2017.11.005. View

13.

Clarke G . Etiology of sperm immunity in women. Fertil Steril. 2008; 91(2):639-43. DOI: 10.1016/j.fertnstert.2007.11.045. View

14.

Anukam K, Osazuwa E, Osemene G, Ehigiagbe F, Bruce A, Reid G . Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006; 8(12-13):2772-6. DOI: 10.1016/j.micinf.2006.08.008. View

15.

Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U . Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat Med. 2019; 25(10):1500-1504. DOI: 10.1038/s41591-019-0600-6. View

16.

Aldunate M, Srbinovski D, Hearps A, Latham C, Ramsland P, Gugasyan R . Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015; 6:164. PMC: 4451362. DOI: 10.3389/fphys.2015.00164. View

17.

Mitchell C, Marrazzo J . Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol. 2014; 71(6):555-63. PMC: 4128638. DOI: 10.1111/aji.12264. View

18.

Kissinger P, Gaydos C, Sena A, McClelland R, Soper D, Evan Secor W . Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022; 74(Suppl_2):S152-S161. PMC: 9006969. DOI: 10.1093/cid/ciac030. View

19.

Pradines B, Domenichini S, Lievin-Le Moal V . Adherent Bacteria and Parasiticidal Secretion Products of Human Cervicovaginal Microbiota-Associated Confer Non-Identical Cell Protection against -Induced Cell Detachment. Pharmaceuticals (Basel). 2022; 15(11). PMC: 9696988. DOI: 10.3390/ph15111350. View

20.

Wiik J, Sengpiel V, Kyrgiou M, Nilsson S, Mitra A, Tanbo T . Cervical microbiota in women with cervical intra-epithelial neoplasia, prior to and after local excisional treatment, a Norwegian cohort study. BMC Womens Health. 2019; 19(1):30. PMC: 6364458. DOI: 10.1186/s12905-019-0727-0. View